Walmart to offer free diabetes GLP-1 drugs and 250+ no-cost prescriptions to employees in 2027

Walmart will cover certain GLP-1 medications for Type 2 diabetes at no cost to eligible employees starting in 2027, as part of an expansion that includes more than 250 free prescription drugs, Fox Business reported. The report cites an Oct. 13 letter to employees from Chief People Officer Donna Morris. We have not independently seen the letter, and only Fox Business has this story among the outlets we track, so treat the details as that outlet's reporting.

What is reportedly changing

• Expanded prescription coverage under most of its medical plans, including certain insulin products and inhalers.
• A wider Centers of Excellence program for employees evaluated for or diagnosed with multiple sclerosis, Parkinson's disease or ALS, with no-cost evaluations and treatment reviews with specialists at Mayo Clinic or Cleveland Clinic.
• Up to 12 weeks of paid leave for employees whose children are in neonatal intensive care.

Existing benefits continue, including 20 no-cost mental health therapy sessions a year and up to $20,000 for fertility treatment, adoption or surrogacy, per Fox Business. Open enrollment is under way.

The catch

Fox Business noted Walmart also plans to raise premiums for its starting health plan, citing Reuters. The free-drug expansion is covered for Type 2 diabetes GLP-1s, not for weight-loss use generally, as the report describes it.

What it means for business owners

Walmart is the largest private employer in the U.S., so its benefit design sets a reference point for frontline workers who compare offers. Small employers cannot match it, but they can see where the cost pressure is: GLP-1 drugs are among the costliest items for health plans, and a company with Walmart's size and pharmacy business has leverage a nine-person shop does not.

• If you run a small group plan: ask your broker at renewal how GLP-1 coverage is priced and whether a diabetes-only carve-in is available.
• If you hire hourly workers: benefits are a recruiting line Walmart is now competing on; compare total package, not wage alone.
• Investors: Walmart did not disclose a cost figure in the reporting, so there is no earnings estimate to draw from this.

Sources: Fox Business, citing a Walmart letter to employees and Reuters. This is market information, not investment advice.